More restrictive lung disease
Getting the most out of therapy
What is restrictive lung disease?
Reference
-
Shneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J. 2002; 20:480-487
Africa & Middle East
Americas
Asia Pacific
Treating a patient with respiratory failure associated with a restrictive lung disease, mainly chest wall disorder, can help alleviate some of the symptoms of poor respiration, including:
Indications for NIV for the treatment of respiratory failure include symptoms or signs of corpulmonale, and one of the following:
Noninvasive ventilation (NIV) is an effective treatment option for hypercapnic respiratory failure in patients with a chest wall disorder.1
ResMed is committed to improving the quality of life for patients with chest wall disorders through the use of home NIV systems.
In recent years, NIV used with a leak circuit and a volume-assurance target has been established as a very effective method of reducing PtcCO2.
ResMed’s Volume-Assurance mode, iVAPS (intelligent Volume-Assured Pressure Support) not only secures target volume but also alveolar ventilation by compensating for dead space ventilation. This is particularly important as patient conditions may change during the night; for example, respiratory drive is sometimes impaired during rapid eye movement (REM) sleep or when the patient moves to a supine position.
Some ResMed ventilators also feature NIV+ trigger technology that’s sensitive enough that it can detect even the weakest breath, triggering the ventilator to deliver the next breath for the patient so that breathing isn’t delayed.
iVAPS is available in the following ResMed devices used to treat respiratory failure associated with chest wall disorders:
Chest wall disorders are progressive and may require ventilator settings to be adjusted, based on how the patient’s condition changes.
Shneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J. 2002; 20:480-487